During the past decade, Neurology Research Inc conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Research Inc" #1 collaborator was "Eisai Inc." with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Research Inc" are "Alzheimer's Disease" (2 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Neurology Research Inc" in a lesser frequency.

Most popular intervention types in "Neurology Research Inc" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bapineuzumab" (1 trials) and "Rasagiline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Research Inc" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Research Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Neurology Research Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Research Inc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".